Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Packaging & closure defects

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination.

318 FDA drug recalls with this cause, newest first.

These recalls involve the container rather than the contents - failed child-resistant closures, leaking bags or vials, cracked cartridges, blister packs with holes, or a delivery device (pump, applicator, syringe) that does not work as designed. A seal problem can let contamination in after the product leaves the factory, and a failed child-resistant cap puts children at risk of accidental exposure.

Total recalls
318
Class I (high risk)
23
Currently ongoing
80
Most recent
Aug 28, 2026

Most-cited firms for this cause

  • Noven Pharmaceuticals, Inc.32
  • Noven Pharmaceuticals Inc16
  • Glenmark Pharmaceuticals Inc., USA12
  • Teva Pharmaceuticals USA11
  • Safecor Health, LLC11
  • FDC Limited11
  • Aurobindo Pharma USA Inc.9
  • Novocol Pharmaceutical of Canada, Inc.7
Class II · Moderate risk

Exenatide Injection

Defective Delivery System: Possibility of no medication in the prefilled pen.

Ongoing Packaging defect Amneal Pharmaceuticals of New York, LLC NDC 70121-1685-1 D-0868-2026
Class II · Moderate risk

safco SensiCaine-Ultra

Defective container:may contain bottles with incomplete seals

Ongoing Packaging defect Keystone Industries NDC 67239-0223-1 D-0606-2026
Class II · Moderate risk

PureLife

Defective container:may contain bottles with incomplete seals

Ongoing Packaging defect Keystone Industries NDC 68987-001-30 D-0605-2026
Class II · Moderate risk

Quala Dental Products

Defective container:may contain bottles with incomplete seals

Ongoing Packaging defect Keystone Industries NDC 43128-034-30 D-0601-2026
Class II · Moderate risk

Estradiol Gel

Defective Container; packets were found to be either empty or partially full.

Ongoing Packaging defect ANI Pharmaceuticals, Inc. NDC 70954-531-20 D-0543-2026
Class II · Moderate risk

Desmopressin Nasal Spray

Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.

Ongoing Packaging defect Apotex Corp. NDC 60505-0815-0 D-0510-2026
Class II · Moderate risk

Oxycodone Hydrochloride Tablets

Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.

Ongoing Packaging defect Amerisource Health Services LLC NDC 68084-354-01 D-0338-2026
Class II · Moderate risk

Ondansetron Orally Disintegrating Tablets

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Ongoing Packaging defect Glenmark Pharmaceuticals Inc., USA NDC 68462-157-13 D-0246-2026
Class II · Moderate risk

Ondansetron ODT Tablets

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Ongoing Packaging defect Preferred Pharmaceuticals, Inc. NDC 68788-8666-01 D-0239-2026
Class II · Moderate risk

OraVerse

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 0362-0101-10 D-0234-2026
Class II · Moderate risk

Cook-Walte

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 0362-0753-05 D-0233-2026
Class II · Moderate risk

darby dental supply

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 66467-9760-5 D-0231-2026
Class II · Moderate risk

3% Polocaine DENTAL

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 66312-441-16 D-0230-2026